Glickman Urological & Kidney Institute Outcomes
Surgical Quality Improvement
Prostatectomy Outcomes
Prostatectomy ACS NSQIP Outcomes
January 1, 2023 – December 31, 2023
The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) objectively measures and reports risk-adjusted surgical outcomes based on a defined sampling and abstraction methodology. These outcomes data reflect Cleveland Clinic’s prostatectomy ACS NSQIP performance benchmarked against 113 participating sites.
| Prostatectomy (113 Sites) | N | Observed | Expected |
|---|---|---|---|
| 30 Day Morbidity | 236 | 2.54% | 4.98% |
| Renal Failure | 236 | 0.85% | 0.26% |
| Urinary Tract Infection (UTI) | 236 | 0.42% | 2.40% |
| Surgical Site Infection (SSI) | 236 | 0.85% | 1.81% |
| Sepsis | 236 | 0.42% | 0.64% |
| Unplanned Reoperation | 236 | 0.42% | 0.68% |
| Unplanned Readmission | 236 | 2.97% | 4.10% |
| Anastomotic Leak | 236 | 0.85% | 0.50% |
| Rectal Injury | 236 | 0.00% | 0.12% |
| Prolonged NPO/NGT Use | 236 | 1.69% | 0.71% |
| Ureteral Obstruction | 236 | 0.00% | 0.14% |
| Urinary Leak/Fistula | 236 | 1.27% | 1.16% |
| Lymphocele/Leak/Fluid | 236 | 0.42% | 1.31% |
American College of Surgeons National Surgical Quality Improvement Program, 2024.
ACS NSQIP® Semiannual Report July 8, 2024, Chicago: American College of Surgeons.
